GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per month at more than 70,000 pharmacies nationwide via GoodRx. For consumers looking to easily evaluate their options for both treatment and access to the medication, they will soon be able to connect with a licensed healthcare provider through GoodRx for Weight Loss to determine eligibility and obtain a prescription when appropriate. The arrival of the Wegovy pill on GoodRx represents a significant step forward in making GLP-1 treatments more affordable and accessible for people looking to begin or advance their weight-loss journey.
“We’re excited to help consumers access one of the most anticipated weight-loss treatments on the market,” said Wendy Barnes, President and CEO of GoodRx. “As new oral GLP-1 options emerge, GoodRx is uniquely positioned to support patients as they navigate their treatment choices. By combining transparent cash pricing with streamlined access to care and broad pharmacy availability, we’re helping usher in a simpler, more consumer-friendly chapter in weight management treatment.” Read More >
